October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S. installation of a Trinias SCORE Opera C12 (ceiling mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC). The system was installed by Shimadzu’s dealer partner, CMS Imaging (North Charleston, SC).  


As hospitals begin replacing their first-generation 64-slice computed tomography (CT) scanners after a decade of use, there are several considerations evaluation teams should think about when looking at the newer-generation scanners. Chief among these is the idea that more slices makes for a better scanner — which CT experts say is not necessarily the case. There are costs versus benefits to consider when looking at high-slice systems.


October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT (CCT) scanners.

October 13, 2023 — InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S.

October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone software for ECG analysis. The Cardiomatics ECG interpretation platform is used by more than 200 clinics and 1,000 medical professionals.

October 12, 2023 — Royal Philips, a global leader in health technology, and the 

October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which houses a needle and ultrasound in one system for use in atrial transseptal procedures and delivery of catheters, has now been successfully used in 15 human cases, at major cardiology hospitals in Arizona and Minnesota. 

October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces completion of enrollment in its 

October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications almost a year later, a national study led by Nanyang Technological University, Singapore (NTU Singapore) and affiliated faculty has found. 

October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today released new data for TN-301 at the 2023 Heart Failure Society of America (HFSA) Annual Scientific Meeting.

Subscribe Now